Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
NEO-RT
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- NCT06205485 ↗
- Recruiting
- Canadian Cancer Trials Group
- Standard
We haven't built an HCP commentary report on NEO-RT (FOLFOX; CAPOX in early rectal cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NEO-RT so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 20 |
The trial
ClinicalTrials.gov- Official title
- A Phase 3 Randomized Trial Of Neoadjuvant Chemotherapy, Excision And Observation Versus Chemoradiotherapy For Early Rectal Cancer
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Rectal Cancer
- Interventions
- Leucovorin; Oxaliplatin; Fluoruracil; Capecitabine; Radiation
- Arms
- FOLFOX OR CAPOX · Active comparator
- ChemoRT · Active comparator
- Enrollment
- 250 (estimated)
- Primary outcomes
- Clinical response rate upon re-staging
- Quality of Life defined using the LARS score
- Sponsor
- Canadian Cancer Trials Group with Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group, NRG Oncology, SWOG Cancer Research Network
- Start
- Jun 26, 2024
- Primary completion
- Jan 30, 2030 (estimated)
- Results posted
- No
- Registry record
- NCT06205485 · updated Jul 14, 2026